Key facts
- Notable investors include iAccel (Seongnam-si).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Union Haus
- ·The full record, as it builds
Funding rounds
No funding rounds for Union Haus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Union Haus
Operator of plant redesign technology intended to create functional raw materials from engineered plants. The company offers gene editing technology, plant vector design, and plant-derived ingredient development, enabling agriculture, food, supplement, and cosmetics manufacturers to access specialized plant-based raw materials for product development.
- Sector
- Healthcare
- HQ
- Gyeongsan-si, South Korea
- Founded
- 2024
- Employees
- 4
- Website
- union-haus.imweb.me/
- Ownership
- Privately Held (backing)
Union Haus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Union Haus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Union Haus in its N-PORT filings yet. We sweep new filings monthly.